Search research articles
Contact Us
Filters
Showing results (231-240 of 275) with videos related to
Page
of 28
Sort By:
Infection and Immunity
|
May 1, 1970
Subcellular Localization of Salmonella enteritidis Endotoxin in Liver and Spleen of Mice and Rats
J T Willerson, R L Trelstad, T Pincus, et al.
The American Journal of Medicine
|
March 1, 1986
Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis
W W Ellis, A N Baer, R M Robertson, et al.
Rheumatology (Oxford, England)
|
December 7, 2002
Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review
T Pincus, G Ferraccioli, T Sokka, et al.
Radiology
|
December 1, 1987
Rheumatoid arthritis: explanatory power of specific radiographic findings for patient clinical status
J J Kaye, L F Callahan, E P Nance, et al.
Family Practice
|
July 3, 2007
Prevalence and comparative troublesomeness by age of musculoskeletal pain in different body locations
S Parsons, A Breen, N E Foster, et al.
The Journal of Rheumatology
|
February 7, 1998
Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker stage, Kaye modified Sharp score, and Larsen score
T Pincus, A Larsen, R H Brooks, et al.
British Journal of Rheumatology
|
January 1, 1988
HLA-DR4 and other genetic markers in rheumatoid arthritis
P Stastny, E J Ball, M A Khan, et al.
Annals of the Rheumatic Diseases
|
March 1, 2006
Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities
C P Chung, J L Thompson, G G Koch, et al.
Arthritis and Rheumatism
|
March 13, 2003
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial
T Pincus, V Strand, G Koch, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
|
March 3, 1998
Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years
L F Callahan, T Pincus, J W Huston, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 275) with videos related to
Sort By:
Page
of 28
Infection and Immunity
|
May 1, 1970
Subcellular Localization of Salmonella enteritidis Endotoxin in Liver and Spleen of Mice and Rats
J T Willerson, R L Trelstad, T Pincus, et al.
The American Journal of Medicine
|
March 1, 1986
Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis
W W Ellis, A N Baer, R M Robertson, et al.
Rheumatology (Oxford, England)
|
December 7, 2002
Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review
T Pincus, G Ferraccioli, T Sokka, et al.
Radiology
|
December 1, 1987
Rheumatoid arthritis: explanatory power of specific radiographic findings for patient clinical status
J J Kaye, L F Callahan, E P Nance, et al.
Family Practice
|
July 3, 2007
Prevalence and comparative troublesomeness by age of musculoskeletal pain in different body locations
S Parsons, A Breen, N E Foster, et al.
The Journal of Rheumatology
|
February 7, 1998
Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker stage, Kaye modified Sharp score, and Larsen score
T Pincus, A Larsen, R H Brooks, et al.
British Journal of Rheumatology
|
January 1, 1988
HLA-DR4 and other genetic markers in rheumatoid arthritis
P Stastny, E J Ball, M A Khan, et al.
Annals of the Rheumatic Diseases
|
March 1, 2006
Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities
C P Chung, J L Thompson, G G Koch, et al.
Arthritis and Rheumatism
|
March 13, 2003
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial
T Pincus, V Strand, G Koch, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
|
March 3, 1998
Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years
L F Callahan, T Pincus, J W Huston, et al.
Page
of 28